Hydrocortisone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 29 USDMF, 14 CEP/COS, 6 JDMF, 5 EU WC, 10 KDMF, 39 NDC API, 1 VMF, 25 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

381 FDF Dossiers, 227 FDA Orange Book, 83 Europe, 13 Canada, 6 Australia, 27 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%, CREAM;TOPICAL - 5%;1%, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc, 8 SPI Pharma, 2 Seqens, 16 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 13 Gangwal Healthcare, 24 Nanjing Well Pharmaceutical, 5 Pfanstiehl, 22 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 42 BASF, 3 BioSpectra, 1 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 6 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 3 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 9 Lubrizol Life Science Health, 17 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 33 Roquette, 21 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

88 Topical, 76 Fillers, Diluents & Binders, 57 Solubilizers, 57 Thickeners and Stabilizers, 44 Parenteral, 40 Direct Compression, 30 Coating Systems & Additives, 29 Disintegrants & Superdisintegrants, 29 Lubricants & Glidants, 28 Granulation, 27 Emulsifying Agents, 24 Controlled & Modified Release, 20 Co-Processed Excipients, 20 Film Formers & Plasticizers, 20 Surfactant & Foaming Agents, 18 Taste Masking, 11 Chewable & Orodispersible Aids, 8 Rheology Modifiers, 5 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 46 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 91 Finished Drug Prices, 1 Annual Reports

MARKET PLACE

28 APIs, 16 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 3 JP, 5 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50168 / DOSAGE - OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BACITRACIN ZINC(UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I)	BACITRACIN	400[iU] in 1
HYDROCORTISONE(UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ)	HYDROCORTISONE	10mg in 1
NEOMYCIN SULFATE(UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297)	NEOMYCIN	3.5mg in 1
POLYMYXIN B SULFATE(UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K)	POLYMYXIN B	5000[iU] in 1

Inactive Ingredients

Ingredient Name	Pfizer Laboratories Div Pfizer Inc
PETROLATUM(4T6H12BN9U)

Drug Product Composition: Hydrocortisone

Hydrocortisone

Hydrocortisone

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers

29 USDMF

14 CEP/COS

6 JDMF

5 EU WC

10 KDMF

39 NDC API

1 VMF

25 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

381 FDF Dossiers

227 FDA Orange Book

83 Europe

13 Canada

6 Australia

27 South Africa

25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%

CREAM;TOPICAL - 5%;1%

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 1%

TABLET;ORAL - 10MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

5 Rochem International Inc

8 SPI Pharma

2 Seqens

16 DKSH

2 Jai Radhe Sales

1 Pharm-RX Chemical

7 Faran Shimi Pharmaceutical

13 Gangwal Healthcare

24 Nanjing Well Pharmaceutical

5 Pfanstiehl

22 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

42 BASF

3 BioSpectra

1 Clariant

15 Corel Pharma Chem

7 DFE Pharma

6 Finar

16 Gangwal Chemicals

2 Hayashibara

3 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

31 Kerry

9 Lubrizol Life Science Health

17 Microlex e.U

3 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

33 Roquette

21 Seppic

2 Shandong Focus Biotechnology Co., Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

2 Valens Pharmachem

5 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons